You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 22, 2024

Details for New Drug Application (NDA): 020298

✉ Email this page to a colleague

« Back to Dashboard

NDA 020298 describes ALOPRIM, which is a drug marketed by Mylan and is included in one NDA. It is available from two suppliers. Additional details are available on the ALOPRIM profile page.

The generic ingredient in ALOPRIM is allopurinol sodium. There are twenty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the allopurinol sodium profile page.
Summary for 020298
Ingredient:allopurinol sodium
Formulation / Manufacturing:see details
Pharmacology for NDA: 020298
Mechanism of ActionXanthine Oxidase Inhibitors
Suppliers and Packaging for NDA: 020298
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALOPRIM allopurinol sodium INJECTABLE;INJECTION 020298 NDA HF Acquisition Co LLC, DBA HealthFirst 51662-1323 51662-1323-1 1 KIT in 1 KIT (51662-1323-1) * 1 mL in 1 VIAL * 1 mL in 1 SYRINGE
ALOPRIM allopurinol sodium INJECTABLE;INJECTION 020298 NDA Mylan Institutional LLC 67457-187 67457-187-50 1 VIAL, GLASS in 1 CARTON (67457-187-50) / 25 mL in 1 VIAL, GLASS

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 500MG BASE/VIAL
Approval Date:May 17, 1996TE:APRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.